Topline Capital Management, LLC, along with its managing member Collin McBirney, disclosed significant stock sales in Paysign, Inc. (NASDAQ:PAYS) according to recent SEC filings. The company, which has shown strong revenue growth of 27.75% over the last twelve months and maintains a healthy gross profit margin of 53.37%, is currently trading below its InvestingPro Fair Value. From December 27 to December 31, the firm sold a total of 479,105 shares of Paysign common stock, amounting to approximately $1,525,503. The shares were sold at prices ranging from $3.03 to $3.31 per share. Following these transactions, the firm retains ownership of 5,611,128 shares. These transactions were conducted by Topline Capital Partners (WA:CPAP), LP, a Delaware limited partnership, with Topline Capital Management acting as the investment manager and general partner. InvestingPro analysis reveals 7 additional key insights about PAYS, available in the comprehensive Pro Research Report, which helps investors make informed decisions through expert analysis of 1,400+ top stocks.
In other recent news, Paysign, Inc. has reported a 23% increase in revenue to $15.3 million during its latest earnings call, along with a 20.6% rise in adjusted EBITDA to $2.8 million. The company has also announced plans to expand its program offerings and a partnership with a leading pharmaceutical company. Despite facing challenges in its plasma business and ongoing investments, Paysign has projected revenues between $56.5 million and $58.5 million for the remainder of the year, with a net income guidance of $3 million to $3.5 million.
Furthermore, Paysign's patient affordability segment has seen a substantial surge, with an increase by 219% and 66 active programs. The company also reported a growth of 3.4% in plasma donor compensation revenue to $11.4 million. Gross margins have improved, reaching 55.5%.
In addition, Paysign anticipates a year-over-year revenue growth of 20% to 24% and projects gross profit margins at 54% to 55%. The company's operating expenses are expected to fall between $30 million and $32 million. These recent developments reflect Paysign's ongoing commitment to growth and financial stability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.